Author

D. Rutishauser

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Biochemistry· 1 Cancer Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:differential expression· 2 Organism:human· 2 Assay:proteomics· 2 Approach:experimental assay· 1 Approach:machine learning (classical)· 1

Frequent Co-Authors

B. Wang· 2 shared C. Fankhauser· 2 shared C. Poyet· 2 shared Q. Zhong· 2 shared R. Aebersold· 2 shared T. Guo· 2 shared T. Zhu· 2 shared A. Anees· 1 shared

Activity by Year

2019-2023 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 43 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersCancer Biology

B. Wang

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Proteomic-based stratification of intermediate-risk prostate cancer patients

Q. Zhong, S. Rui, A. T. Aref, Z. Noor, A. Anees, Y. Zhu, N. Lucas, R. C. Poulos, M. Lyu, T. Zhu, B. Wang, G.-B. Chen, Y. Wang, X. Ding, D. Rutishauser, , P. J. Wild

The paper identifies an 18-protein signature from proteomic data to stratify intermediate-risk prostate cancer patients into low- and high-risk groups for biochemical recurrence.

bioRxiv · Mar 3, 2023Cancer Biology

High-throughput proteomic analysis of FFPE tissue samples facilitates tumor stratification

Y. J. Zhu, T. Weiss, Q. Zhang, R. Sun, B. Wang, Z. Wu, Q. Zhong, X. Yi, H. Gao, X. Cai, G. Ruan, T. Zhu, C. Xu, S. Lou, X. Yu, , T. Guo

This study develops a proteomic workflow for FFPE tissues to stratify prostate cancer and DLBCL samples, identifying MPO as a prognostic marker and showing FFPE's utility for biomarker discovery.

bioRxiv · Jun 11, 2019Biochemistry